Allurion Technologies, Inc. (ALUR)
1.68
-0.02
(-1.18%)
USD |
NYSE |
Jan 09, 16:00
1.67
-0.01
(-0.60%)
After-Hours: 20:00
Allurion Technologies EPS Diluted (Quarterly): -1.531 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Boston Scientific Corp. | 0.5048 |
| Insulet Corp. | 1.240 |
| Perspective Therapeutics, Inc. | -0.3495 |
| InfuSystem Holdings, Inc. | 0.1078 |
| Xtant Medical Holdings, Inc. | 0.0087 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -11.88M |
| Revenue (Quarterly) | 2.658M |
| Total Expenses (Quarterly) | 14.54M |
| Enterprise Value | 47.90M |
| Gross Profit Margin (Quarterly) | 44.43% |
| Profit Margin (Quarterly) | -447.1% |
| Earnings Yield | -344.9% |
| Normalized Earnings Yield | -547.02 |